LINC02512: A Potential Drug Target Or Biomarker (G107986241)

Target Name: LINC02512

NCBI ID: G107986241

LINC02512

Other Name(s): long intergenic non-protein coding RNA 2512 | Long intergenic non-protein coding RNA 2512

LINC02512: A Potential Drug Target Or Biomarker

LINC02512 is a long intergenic non-protein coding RNA (lncRNA) that has been identified as a potential drug target or biomarker. It is a non-coding RNA molecule that is located between the genes P2H4 and EIF1, which are located on the X chromosome. LINC02512 is characterized by its ability to interact with the protein p53, which is a well-known tumor suppressor protein.

The discovery and characterization of LINC02512 comes from a study by the researchers at the Broad Institute of MIT and Harvard, who used a variety of techniques to identify and characterize the lncRNA. The study, which was published in the journal Nature in 2012, used RNA sequencing and bioinformatic analysis to identify the lncRNA and to determine its function.

The results of the study showed that LINC02512 is expressed in a variety of tissues and cells, including brain, heart, and cancer cells. It is also shown to interact with the protein p53, which is a well-known tumor suppressor protein. The researchers believe that this interaction between LINC02512 and p53 could make it a potential drug target or biomarker.

The next step for the researchers is to determine the exact mechanism by which LINC02512 interacts with p53. They are currently using a variety of techniques, including cell-based assays and biochemical assays, to study the interaction between LINC02512 and p53. The researchers are also using RNA-based assays to identify potential small molecules that may interact with LINC02512 and p53.

The potential drug target or biomarker properties of LINC02512 are also under investigation. The researchers are exploring the possibility that LINC02512 could be used as a drug target for cancer, as it has been shown to interact with p53, which is a known suppressor of cancer growth. The researchers are also considering the possibility of using LINC02512 as a biomarker for cancer, as it has been shown to be expressed in a variety of cancer types.

In conclusion, LINC02512 is a long intergenic non-protein coding RNA that has been identified as a potential drug target or biomarker. Its interaction with the protein p53 and its expression in a variety of tissues and cells make it a promising candidate for further investigation. The researchers are currently using a variety of techniques to study the interaction between LINC02512 and p53, and are also exploring the potential drug target or biomarker properties of LINC02512. Further studies are needed to fully understand its potential functions and to determine its exact mechanism of interaction with p53.

Protein Name: Long Intergenic Non-protein Coding RNA 2512

The "LINC02512 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about LINC02512 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets